News & Updates

Show Multimedia Only

Are plant-based meats living up to their perceived health halos?

20 Nov 2024 by

With the advent of plant-based diets (PBDs), plant-based meat analogues (PBMAs) have emerged as alternative protein sources carrying numerous health benefits. However, a study from Singapore appears to reflect otherwise, showing that PBMAs do not confer cardiometabolic health benefits compared with their animal-based counterparts.

Are plant-based meats living up to their perceived health halos?

20 Nov 2024

Complete response and long-term survival possible with locoregional therapy plus IO in patients with unresectable HCC

20 Nov 2024 by

A cohort study conducted by researchers from the University of Hong Kong (HKU) reports a complete response (CR) rate of 46.0 percent among patients with locally advanced, unresectable hepatocellular carcinoma (HCC) who were treated with locoregional therapy (LRT) plus immunotherapy (IO) and a 3-year overall survival (OS) rate of 75.5 percent among patients with CR.

Complete response and long-term survival possible with locoregional therapy plus IO in patients with unresectable HCC

20 Nov 2024

Induction chemo plus CRT improves PFS and OS vs CRT alone in locally advanced cervical cancer

20 Nov 2024 by

The international, multicentre, randomized phase III GCIG INTERLACE trial reports significantly higher 5-year progression-free survival (PFS) and overall survival (OS) rates with induction chemotherapy followed by chemoradiotherapy (CRT) vs CRT alone in patients with locally advanced cervical cancer.

Induction chemo plus CRT improves PFS and OS vs CRT alone in locally advanced cervical cancer

20 Nov 2024

Does wearing mask during sleep affect cardiopulmonary function in OSA?

19 Nov 2024

Wearing a face mask while sleeping shows no adverse effect on cardiopulmonary function in patients with mild-to-moderate obstructive sleep apnoea (OSA), although it can be uncomfortable, particularly when using the N95 mask, according to a study. A surgical mask may be used as an alternative.

Does wearing mask during sleep affect cardiopulmonary function in OSA?

19 Nov 2024

SGLT-2 inhibitors help avert death in patients with HFrEF

19 Nov 2024 by

Use of SGLT-2 inhibitors may reduce the risk of all-cause and cardiovascular (CV) mortality in patients with heart failure (HF) with reduced ejection fraction (HFrEF), reports a study.

SGLT-2 inhibitors help avert death in patients with HFrEF

19 Nov 2024

Fruit, vegetable diet a viable treatment for hypertension

19 Nov 2024 by

A diet that is rich in fruits and vegetables can help treat individuals with primary hypertension by preventing chronic kidney disease (CKD) progression and reducing the risk of cardiovascular disease (CVD), suggest the results of a recent study.

Fruit, vegetable diet a viable treatment for hypertension

19 Nov 2024

3L EGFR-MET bispecific antibody in a patient with EGFR ex20ins–positive NSCLC after haemorrhagic stroke

19 Nov 2024 by

This was a 60-year-old woman with a history of diabetes and end-stage kidney disease (ESKD) requiring haemodialysis three times a week. She was admitted to the hospital in June 2022 due to shortness of breath and chest tightness lasting for 1 month. Her Eastern Cooperative Oncology Group performance status (ECOG PS) was 2.

3L EGFR-MET bispecific antibody in a patient with EGFR ex20ins–positive NSCLC after haemorrhagic stroke

19 Nov 2024

Dr Elena Elez of Vall d’Hebron University Hospital shares CRC case treated with BEACON regimen

19 Nov 2024

Dr Elena Elez of Vall d’Hebron University Hospital, Barcelona, Spain, shares a case of an elderly patient with colorectal cancer (CRC) treated with the BEACON regimen (encorafenib plus cetuximab).

Dr Elena Elez of Vall d’Hebron University Hospital shares CRC case treated with BEACON regimen

19 Nov 2024

Prof Julien Taieb treats BRAFV600E-mutant mCRC with encorafenib + cetuximab

19 Nov 2024

Professor Julien Taieb of Georges Pompidou European Hospital in Paris, France, shares a case of a 58-year-old female diagnosed with BRAF^V600E-mutant colorectal cancer, whose disease progressed and became metastatic following FOLFOX. Subsequent treatment with pembrolizumab was not tolerated well and the patient was switched to encorafenib plus cetuximab, which led to improvement in patient’s general condition and allowed cytoreductive surgery followed by complete tumour regression.

Prof Julien Taieb treats BRAFV600E-mutant mCRC with encorafenib + cetuximab

19 Nov 2024

Expanding role of SSAs in neuroendocrine tumour management

19 Nov 2024 by

High-dose somatostatin analogues (SSAs) can be effective and well-tolerated second-line therapies in neuroendocrine tumours (NETs) progressing on standard-dose SSAs in selected cases, according to Dr Ingrid Mak of the University of Hong Kong, at the 7th Endocrinology, Diabetes & Metabolism Hong Kong Annual Meeting (EDM HK 2024).

Expanding role of SSAs in neuroendocrine tumour management

19 Nov 2024

News & Updates

Filter by Specialty:

Specialty:

Are plant-based meats living up to their perceived health halos?

Are plant-based meats living up to their perceived health halos?

Complete response and long-term survival possible with locoregional therapy plus IO in patients with unresectable HCC

Complete response and long-term survival possible with locoregional therapy plus IO in patients with unresectable HCC

Induction chemo plus CRT improves PFS and OS vs CRT alone in locally advanced cervical cancer

Induction chemo plus CRT improves PFS and OS vs CRT alone in locally advanced cervical cancer

Does wearing mask during sleep affect cardiopulmonary function in OSA?

Does wearing mask during sleep affect cardiopulmonary function in OSA?

SGLT-2 inhibitors help avert death in patients with HFrEF

SGLT-2 inhibitors help avert death in patients with HFrEF

Fruit, vegetable diet a viable treatment for hypertension

Fruit, vegetable diet a viable treatment for hypertension

3L EGFR-MET bispecific antibody in a patient with EGFR ex20ins–positive NSCLC after haemorrhagic stroke

3L EGFR-MET bispecific antibody in a patient with EGFR ex20ins–positive NSCLC after haemorrhagic stroke

Dr Elena Elez of Vall d’Hebron University Hospital shares CRC case treated with BEACON regimen

Dr Elena Elez of Vall d’Hebron University Hospital shares CRC case treated with BEACON regimen

Prof Julien Taieb treats BRAFV600E-mutant mCRC with encorafenib + cetuximab

Prof Julien Taieb treats BRAFV600E-mutant mCRC with encorafenib + cetuximab

Expanding role of SSAs in neuroendocrine tumour management

Expanding role of SSAs in neuroendocrine tumour management